SCHEMBL6858792

SCHEMBL6858792

COc1ccc(-c2csc(N3CCN(C)CC3)n2)c2sc(NC(=O)c3ccccn3)nc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 3/20 0.46
TRPV4 Q9HBA0 2/20 0.46
ADORA2A P29274 1/20 0.42
ADORA2B P29275 1/20 0.42
ADORA1 P30542 1/20 0.42
KMT2A Q03164 2/20 0.41
HTR1A P08908 1/20 0.41
ADRA1A P35348 1/20 0.41
MAPT P10636 4/20 0.40
HSD17B10 Q99714 2/20 0.40
REV1 Q9UBZ9 1/20 0.40
HTT P42858 1/20 0.40
ALDH1A1 P00352 3/20 0.40
RAB9A P51151 2/20 0.40
RECQL P46063 1/20 0.40
POLB P06746 1/20 0.40
TSHR P16473 1/20 0.40
KDM4E B2RXH2 1/20 0.40
NPC1 O15118 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6858781 0.90 CHRM4 (0.46) CHRM4TRPV4ADORA2AADORA2BADORA1
SCHEMBL3046437 0.87 ALDH1A1 (0.44) ADORA2AADORA2BADORA1MAPTHSD17B10
SCHEMBL3048081 0.85 CHRM4 (0.46) CHRM4TRPV4ADORA2AADORA2BADORA1
SCHEMBL3051821 0.85 ADORA2A (0.54) ADORA2AADORA2BADORA1KMT2ANPC1
SCHEMBL3046444 0.80 ALDH1A1 (0.49) CHRM4ADORA2AADORA1MAPTHSD17B10
SCHEMBL3048474 0.80 SMN1; SMN2 (0.46) MAPTREV1ALDH1A1RAB9APOLB
SCHEMBL3037818 0.80 ALDH1A1 (0.51) CHRM4ADORA2AADORA2BADORA1MAPT
SCHEMBL3046735 0.79 CHRM4 (0.48) CHRM4ADORA2AADORA2BADORA1KMT2A
SCHEMBL3039151 0.79 ADORA2A (0.57) ADORA2AADORA2BADORA1KMT2AMAPT
SCHEMBL3048483 0.78 ALDH1A1 (0.47) MAPTHSD17B10REV1ALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6835732-B2 Modulation of the adenosine A2A receptor; cardioprotective agents; antiischemic agents; antihypoxia agents; central nervous system disorders, Alzheimer's disease, Parkinson's disease, anxiolytic agents; antidepressants; analgesics HOFFMAN-LA ROCHE INC. 2004-12-28 US claimed